Welcome to the e-CCO Library!

search
Search by: 
Year: Category: Sub Type:
DOP44: Cancer risk in a high-incidence Inflammatory Bowel Disease population – a Faroese IBD cohort study
Year: 2020
Source: ECCO'20 Vienna
Authors: Jóngerð Maria Miné Midjord
Created: Tuesday, 23 June 2020, 5:40 PM
DOP44: Melatonin Ameliorates Colitis In DSS-fed Mice Via The SIRT1 Pathway
Year: 2024
Source: ECCO'24 Stockholm
Authors: Liu, Jing
Created: Tuesday, 30 April 2024, 5:03 PM
DOP44: Tofacitinib versus corticosteroids for induction of remission in moderately active ulcerative colitis (ORCHID): A prospective randomized open-label pilot study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Arshdeep Singh
Created: Friday, 14 July 2023, 2:22 PM
DOP45: Blood-derived neutrophils give rise to differentially activated populations in the mucosa of active Inflammatory Bowel Disease patients
Year: 2024
Source: ECCO'24 Stockholm
Authors: Veny, Marisol
Created: Tuesday, 30 April 2024, 5:03 PM
DOP45: Increased prevalence but not incidence of myocardial infarction and stroke in patients with Inflammatory Bowel Diseases in Quebec in 1996-2015
Year: 2020
Source: ECCO'20 Vienna
Authors: Péter Laszlo Lakatos
Created: Tuesday, 23 June 2020, 5:40 PM
DOP45: Predicting late responders to filgotinib in patients with moderately to severely active Ulcerative Colitis: A post hoc analysis of SELECTION and SELECTIONLTE
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Katsuyoshi Matsuoka
Created: Friday, 14 July 2023, 2:22 PM
DOP46: Mucosal host-microbe interactions associate with clinical phenotypes in Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Arno Bourgonje
Created: Friday, 14 July 2023, 2:22 PM
DOP46: Tofacitinib for hospitalized acute severe Ulcerative Colitis – the TRIUMPH study
Year: 2024
Source: ECCO'24 Stockholm
Authors: Narula, Neeraj
Created: Tuesday, 30 April 2024, 5:03 PM
DOP47: Characterisation of endoscopic improvement in Crohn’s Disease with upadacitinib treatment
Year: 2024
Source: ECCO'24 Stockholm
Authors: Panaccione, Remo
Created: Tuesday, 30 April 2024, 5:03 PM
DOP47: Gut microbiome contributes to the development of immune checkpoint inhibitor-related colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Xinyu Liu
Created: Friday, 14 July 2023, 2:22 PM
DOP47: The changing pattern of Inflammatory Bowel Disease incidence in Northern France: A continuing increase in the young women (1988-2014)
Year: 2020
Source: ECCO'20 Vienna
Authors: Corinne Gower Rousseau
Created: Tuesday, 23 June 2020, 5:40 PM
DOP48: Faecal microbiota transplantation in active Ulcerative Colitis: Key lessons from a randomized controlled trial halted for futility
Year: 2024
Source: ECCO'24 Stockholm
Authors: Deleu, Sara
Created: Tuesday, 30 April 2024, 5:03 PM
DOP48: Gene expression landscape of epithelial monolayer in Inflammatory Bowel Disease
Year: 2020
Source: ECCO'20 Vienna
Authors: Atle Granlund Van Beelen
Created: Tuesday, 23 June 2020, 5:40 PM
DOP48: Key Anti-Inflammatory Faecalibacterium prausnitzii is Heterogeneous and Diverse in the East and West and in Health and Crohn’s disease. The ENIGMA study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mark Morrison
Created: Friday, 14 July 2023, 2:22 PM
DOP49: Guselkumab improves health-related quality of life as measured by PROMIS-29 in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR induction study
Year: 2024
Source: ECCO'24 Stockholm
Authors: Panés, Julián
Created: Tuesday, 30 April 2024, 5:03 PM
DOP49: Metagenomic Characterisation of The Colonic Mucosa-Associated Microbiota Reveals Novel Microbes and Communities in Health and Crohn’s disease. The ENIGMA study.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Mark Morrison
Created: Friday, 14 July 2023, 2:22 PM
DOP49: Quantitative proteomics analysis of macrophages from Crohn’s Disease patients and infected with adherent-invasive Escherichia coli
Year: 2020
Source: ECCO'20 Vienna
Authors: Anthony Buisson
Created: Tuesday, 23 June 2020, 5:40 PM
DOP50: Impact of Inflammatory Bowel Disease associated dysbiosis on bacterial quorum sensing mediated by Acyl-homoserine Lactone in human gut microbiota
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Nathan Grellier
Created: Friday, 14 July 2023, 2:22 PM
DOP50: PINPOINT: The epidemiology of paediatric-onset Inflammatory Bowel Disease in the United Kingdom – a prospective, national, cohort study.
Year: 2024
Source: ECCO'24 Stockholm
Authors: Henderson, Paul
Created: Tuesday, 30 April 2024, 5:03 PM
DOP50: The landscape of somatic mutations in non-neoplastic IBD-affected colon
Year: 2020
Source: ECCO'20 Vienna
Authors: Carl Anderson
Created: Tuesday, 23 June 2020, 5:40 PM